These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 21387262)
1. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients. Zhu CL; Huang Q; Liu CH; Xie F Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308 [TBL] [Abstract][Full Text] [Related]
3. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome. Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301 [TBL] [Abstract][Full Text] [Related]
4. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies. Xia W; Shi R; Zheng WL; Ma WL Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791 [TBL] [Abstract][Full Text] [Related]
5. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744 [TBL] [Abstract][Full Text] [Related]
6. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis. Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617 [TBL] [Abstract][Full Text] [Related]
7. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Pawlak E; Karabon L; Wlodarska-Polinska I; Jedynak A; Jonkisz A; Tomkiewicz A; Kornafel J; Stepien M; Ignatowicz A; Lebioda A; Dobosz T; Frydecka I Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589 [TBL] [Abstract][Full Text] [Related]
8. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis. Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820 [TBL] [Abstract][Full Text] [Related]
9. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350 [TBL] [Abstract][Full Text] [Related]
10. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis. Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372 [TBL] [Abstract][Full Text] [Related]
12. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease. Du L; Yang P; Hou S; Zhou H; Kijlstra A Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770 [TBL] [Abstract][Full Text] [Related]
13. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis. Han S; Zhang S; Zhang W; Li R; Li Y; Wang Z; Xie Y; Mao Y Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658 [TBL] [Abstract][Full Text] [Related]
14. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism. Goswami R; Gupta N; Ray D; Rani R; Tomar N; Sarin R; Vupputuri MR Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305 [TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation. Tapirdamaz O; Pravica V; Metselaar HJ; Hansen B; Moons L; van Meurs JB; Hutchinson IV; Shaw J; Agarwal K; Adams DH; Day CP; Kwekkeboom J Gut; 2006 Jun; 55(6):863-8. PubMed ID: 16299026 [TBL] [Abstract][Full Text] [Related]
18. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis. Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627 [TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Sun T; Hu Z; Shen H; Lin D Cancer Res; 2009 Aug; 69(15):6011-4. PubMed ID: 19638588 [TBL] [Abstract][Full Text] [Related]
20. [Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity]. Jin P; Xiang B; Lin J; Huang G; Zhou WD; Zheng C; Chao C; Zhou ZG Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1246-9. PubMed ID: 19595177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]